In Canada, most mental health services are embedded in the public health care system. Little is known of the cost distribution within the mental health population. Our study aims to estimate the depression care costs of patients with a depression diagnosis, ranking them by the increasing total depression health care costs.
ICD
International Classification of Diseases
Clinical Implications
• Average costs for depression treatment were highly variable, suggesting vastly different individual levels of need.
• Primary care physicians play an important role in treating people with depression.
• Standardized depression pathways should be considered if treatment is highly variable for people with similar levels of depression severity.
Limitations
• The reported clinician diagnoses cannot be independently verified.
• Drug costs for outpatients are excluded from our study.
I
n Canadian provinces, most mental health services are embedded in the public health care system. Recently, several national [1] [2] [3] and provincial [4] [5] [6] reports have drawn attention to mental health, and both provincial and national initiatives have raised its profile. Throughout the country, provincial public expenditures on mental health were either unknown or not circulated publicly. However, recently published reports indicate how much governments are spending on mental health services. 7, 8 Lim et al 9 estimated that annual Canadian mental health direct and indirect costs were about $5 billion. These studies have been aggregative in nature, and are most useful in making comparisons between jurisdictions or in analyzing trends over time.
The distribution of expenditures among the users of mental health services is important information that can help mental health policy formation. The epidemiologic and economic analysis would be especially useful for specific conditions, such as depression and anxiety, which are common and can cause high health care use. According to the World Health Organization, in the Americas, unipolar depressive disorder is the single highest contributor to disabilityadjusted life years. 10 Lifetime estimates of depression in the adult population, as determined through the Canadian Community Health Survey, are 12.2% for Alberta and 12.1% for Canada.
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Despite its prevalence, relatively few studies have analyzed how much is spent for mental health care on people with depression. The cost of depression studies can be divided into 3 large categories based on the type of the economic analysis: prevalence-based methods that use administrative data, either to estimate costs using a topdown method, estimated from budget and account data [12] [13] [14] ; or bottom-up that is based on patient registry data 15, 16 ; and patient survey or interview-based studies. 17, 18 All of these studies reported the distribution of resource use and costs of depression in total, and on an aggregate level, per capita or per patient, with depression. However, most of these studies have had substantial data limitations owing to the difficulty in obtaining a representative sample of mental health patients.
Although Sobocki et al 16 and von Knorring et al 15 used the bottom-up approach, as in our study, their methodologies were different and their studies did not link all depression costs from all patients with depression individually. Sobocki et al 16 estimated aggregated costs of depression in Europe using country-specific registries, and von Knorring et al 15 analyzed the cost of severe depression using data from a naturalistic drug trial. In a systematic review of the costof-illness studies of depression, Luppa et al 19 found 24 studies with substantial differences in costing and study methodology. Among national studies, the direct medical costs varied between US$244 and US$2488 (in 2003) based on the health care system and patients included. 19 Our study is the first to report annual cumulative depression treatment costs by deciles for all patients with a depression diagnosis in a large geographic area.
In Alberta, the public medical care system maintains episodic records for all people who receive physician, hospital, and outpatient services. For each visit, a diagnosis code is reported, which allows for the identification of care for depression. Since 2003, there has been a program to measure the costs for all people who used mental health services. A key feature of this ongoing program is that it allows for the identification and costing of all publicly funded mental health services used for virtually the entire population. Our study aimed to estimate the health care cost of depression of patients with at least one depression diagnosis during the year, and to rank groups of patients by their increasing total depression costs. This descriptive study used deciles as the method to create equal categories of the population receiving depression treatment. The advantage of decile-based analysis allows for more insight regarding the range of costs beyond what is achievable through averages.
Conclusion : Les coûts par personne étaient hautement asymétriques. Jusqu'au neuvième décile, les coûts augmentaient lentement, et consistaient surtout en des frais de médecins. Dans le dernier décile, les coûts s'accroissaient substantiellement, surtout à cause des hospitalisations. Ainsi, tant les soins de première ligne que les soins des spécialistes jouent des rôles clés.
Method
The provincial ministry of health (AHW) maintains records of all patient contacts with the provincial public health care system for the entire population (3.6 million people in 2008). These records include visits to family doctors, psychiatrists, other specialists, emergency departments, outpatient centres, community, mental health clinics, and hospital inpatient facilities. All people permanently living in Alberta are identified in a provincial registry using a unique identifying number that is assigned by the province. This unique patient identifier allows for the amalgamation of data for each person across the continuum of care. Per service costs have been estimated for each type of service, and can be merged as well to form an estimate of the cost of depression services for each individual service recipient. Publicly funded health services provided on First Nation reserves and through Canadian Armed Forces are not included in these records.
For the fiscal year 2007/08 (April 1, 2007, through March 31, 2008), we selected people who had at least 1 visit to a publicly funded health provider for treatments of depression. An ICD-9, Clinical Modification, code is recorded for each physician visit, the ICD-10 version was used for emergency department and acute inpatient visits. The specific diagnostic codes within ICD-10 that we used to select depression cases were F32.0-F32.3, F32.8, F32.9, F33.0-F33.4, F33.8, F33.9, and F53.0. For those service areas recording diagnostics with ICD-9, we used codes 296.2-296.26, 296.3-296.36, 300.4, 300.5, and 311 as being indicative of depression. 20 To be considered a patient in our study, a person required a primary depression diagnosis from a clinician for each depression-specific service event. People for whom depression was a comorbid diagnosis were excluded from our study. Our study restricted service and cost analysis to the depression-specific diagnoses. People with depression who received other mental health or physical health services only had their depression-related treatment and associated costs included in the study.
Acute hospital inpatient services are identified from the provincial Discharge Abstract Database summaries, which are reported to the CIHI. These summaries include, among other items, patient age and sex, as well as primary and other diagnoses, using ICD. Acute hospital outpatient clinic and emergency services are both reported using ICD codes, which are then grouped using the provincial ambulatory care reporting system (ACCS), maintained by AHW. 21 Community mental health clinic visits and psychiatric facility inpatient cases are reported to the provincial addiction and mental health portfolio of Alberta Health Services, using depression codes within the DSM-IV. 22 A crosswalk is used to ensure congruence between the diagnostic codes within the ICD and DSM taxonomies (Alberta Mental Health Board, Calgary Health Region, 2002). Physician services are obtained from the AHW billing records, which include for each service the diagnostic code, the service provided, the fee paid for the service, and the specialty of the doctor (Alberta Health Care Insurance Plan, 2011). 23 Unit costs for acute hospital inpatient services are obtained according to the CMG-Plus, which is a classification system maintained by the CIHI. 24 Costs are assigned to each CMG-Plus group by AHW. 21 The inpatient costs include direct costs, such as health provider fees and salaries, supervision, supplies, and equipment. Indirect costs are also included and capture items such as information technology, registration, finance, human resources, and support services. Acute hospital outpatient clinic and emergency services are provided according to ACCS code. Community mental health clinic and psychiatric inpatient services are determined by the 2003 fiscal year budget and adjusted by a 3% rate of inflation annually. Physician services are paid a fee by AHW for each service on the provincial fee schedule. 23 Costs were summed by major categories for each person. We then divided the served population into 10 equal size groups. We reported costs by decile for the bottom 9 groups. We further divided costs in the top decile into 10 percentile groups, and reported these costs by percentile.
Results
In 2007/08, of the total population of 3 512 000, there were 208 167 people (5.9%) who had recorded at least 1 visit to the health care system and had a diagnosis of depression. The total cost for all depression-related health care services was $114.5 million, or an average $550 for each person who received at least 1 service for depression.
Per person unit costs were highly skewed (Figure 1 ). For patients in the first 9 deciles, most of the costs were for general practitioner visits. Average costs rose modestly for the first 9 deciles, with those in the first decile having an average cost of $29. By the ninth decile, cost per person rose to about $400. People in the last decile showed a large increment, and accounted for 79.2% of the provincial costs for depression. Within the highest decile, the costs increased regularly, going through the 98th percentile (Table 1) . However, in the top 1% of all cases-the 99th percentile-there was an increase of cost per patient to $25 826 from $5792. Hospital-based costs do not become a factor until the tenth decile. Within the tenth decile, hospital costs become increasingly prominent contributors to the total cost. Within the highest percentile, the 2081 of 208 167 people treated for depression accounted for 46.7% of all costs. Sixty-five per cent of these top percentile costs were for general hospital inpatients, although costs also increased in all categories. Within this top percentile (n = 2081), 1449 were hospitalized in general hospital facilities. These people generated 1873 separate discharges, with an average stay of 34 days. 
Discussion
The overall average cost of $550 per treated person in our study is within the range of average case costs reported in other studies (see Luppa et al 19 ) . The inclusion of a decilebased analysis in our study demonstrates the wide range in costs among the treated population. The costs ranged from $29 for the lowest decile to $25 826 for the highest 1%.
Several factors are worth exploring regarding their potential impact on the range of costs observed in our study. First, differing levels of individual need likely contribute a great degree to the range and variety of services and resultant expenditures for depression cases. For example, of over 200 000 people treated for depression in our study, only the top decile received inpatient hospitalization. Within the context of need, the complexity of comorbid mental health and other health conditions may also influence the results, especially for the higher-cost deciles. The portion of the variance that is explainable based on need is not quantifiable within our study. Second, it may also be that access to services determines, to some degree, the variety and amount of services available to people with depression. Exploration of this access-related factor goes beyond the scope of our study. Both the impact of individual need, based on depression severity and the role of access to services, are suggested areas of further research.
In terms of limitations, while we captured most areas of mental health care in our analysis, we excluded outpatient drugs, many of which are not covered under the provincial health plan. All patients identified at any point in the fiscal year were included. However, patients identified in the later days of the fiscal year would have less opportunity to have their full case costs included. Therefore, the total depression treatment costs are not fully captured for all patients. No adjustments were made for levels of functional severity. No assessments of the quality of care provided were made.
Our study has several clinical implications. There is a need to recognize the central role of primary care in depression. Family physicians are prominent providers in all of the deciles. In the first 6 deciles, family doctors are almost the exclusive public provider of depression treatment. Support for family physicians, including communication and access to specialist care and mental health therapists, is warranted.
It is essential that intensive mental health services are available to people in need. For a relatively small portion of the patients with depression, significant treatment resources were required. For patients requiring intensive services, it is essential to facilitate access to specialist (psychiatrist) and inpatient facilities. A challenge will be to provide access to that segment of the population living in more rural, remote areas. Further analysis is warranted to ascertain the degree to which homogeneous care is provided to patients with depression with similar levels of severity. If high variability exists in the treatment of patients with depression, standard pathways of care for depression could be considered. Care pathways, along various component of the care continuum, could contribute to evidence-based care for the varying levels of depression severity and corresponding needs. In the event that such depression-specific pathways are pursued, they should embed appropriate assessment, severity rating, and level of functioning instruments.
Improved clinical outcomes and efficient resource use are reasonable expectations of care pathway implementation.
Future work could also focus on the role that comorbidity plays in understanding costs. Included in the topic of comorbidity could be the impact of depression on the treatment and related costs on people with other health conditions. 
